Initial public offering and financing of biotechnology start-ups: Evidence from Japan

Yuji Honjo and Sadao Nagaoka

Research Policy, 2018, vol. 47, issue 1, 180-193

Abstract: This study explores the initial public offering (IPO) and financing of biotechnology start-ups in Japan. Using a unique data set, we find that biotechnology start-ups initially backed by venture capital (VC) firms and those originating from universities are more likely to go public within a shorter period. Moreover, we find that neither staged financing nor syndication by VC firms is associated with higher IPO value relative to investment. Furthermore, we provide evidence that the timing of IPOs does not depend on equity market conditions in the biotechnology industry, whereas IPO value tends to depend on equity market conditions. We discuss the factors that explain these findings, which contradict findings in previous studies of VC investments.

Keywords: Biotechnology start-up; Initial public offering; Market value; Staged financing; Syndication; Venture capital (search for similar items in EconPapers)
JEL-codes: G32 L65 M13 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (15)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0048733317301798
Full text for ScienceDirect subscribers only

Related works:
Working Paper: Initial Public Offering and Financing of Biotechnology Start-ups: Evidence from Japan (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:respol:v:47:y:2018:i:1:p:180-193

DOI: 10.1016/j.respol.2017.10.009

Access Statistics for this article

Research Policy is currently edited by M. Bell, B. Martin, W.E. Steinmueller, A. Arora, M. Callon, M. Kenney, S. Kuhlmann, Keun Lee and F. Murray

More articles in Research Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu ().